 |
Therapeutics | Medical Technology | Diagnostics |
Company
Details
Wellington contact:
Rolf Dienst
Rolf Dienst
Entry Date: June 1998
Tinnitus is a virtual drug development company developing innovative therapeutics against tinnitus aurium. After successfully conducting preclinical and clinical development until completion of phase IIa, the company has partnered its lead drug candidate with a large pharma company.
Tinnitus FE GmbH
Flueggenstr. 17
80639 Munich
Germany
CEO:
Dr. Werner Zoellner
 |
Wellington Partners portfolio company Proximic offers
a publisher widget that shows content from the internet that is related to the current page. You can see it in action below. Please visit www.proximic.com for more information.